Report cover image

Global Antipyretic Analgesics Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Feb 08, 2025
Length 104 Pages
SKU # APRC19835460

Description

Summary

Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

According to APO Research, The global Antipyretic Analgesics market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Antipyretic Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Antipyretic Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Antipyretic Analgesics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Antipyretic Analgesics include Mallinckrodt Pharmaceuticals, IOL, Anqiu Lu'an Pharmaceutical, Novacyl, BASF, Anhui BBCA Pharmaceuticals, Hubei Biocause, Xinhua Pharm and Granules India Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics.

The Antipyretic Analgesics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Antipyretic Analgesics Segment by Company

Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF

Antipyretic Analgesics Segment by Type

Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Antipyretic Analgesics Segment by Application

Adults
Children

Antipyretic Analgesics Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antipyretic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Analgesics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antipyretic Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

104 Pages
1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Antipyretic Analgesics Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Antipyretic Analgesics Sales Estimates and Forecasts (2020-2031)
1.3 Antipyretic Analgesics Market by Type
1.3.1 Paracetamol
1.3.2 Aspirin
1.3.3 Ibuprofen
1.3.4 Naproxen
1.3.5 Diclofenac
1.3.6 Oxaprozin
1.3.7 Dexibuprofen
1.3.8 Others
1.4 Global Antipyretic Analgesics Market Size by Type
1.4.1 Global Antipyretic Analgesics Market Size Overview by Type (2020-2031)
1.4.2 Global Antipyretic Analgesics Historic Market Size Review by Type (2020-2025)
1.4.3 Global Antipyretic Analgesics Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Antipyretic Analgesics Sales Breakdown by Type (2020-2025)
1.5.2 Europe Antipyretic Analgesics Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Antipyretic Analgesics Sales Breakdown by Type (2020-2025)
1.5.4 South America Antipyretic Analgesics Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Antipyretic Analgesics Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Antipyretic Analgesics Industry Trends
2.2 Antipyretic Analgesics Industry Drivers
2.3 Antipyretic Analgesics Industry Opportunities and Challenges
2.4 Antipyretic Analgesics Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Antipyretic Analgesics Revenue (2020-2025)
3.2 Global Top Players by Antipyretic Analgesics Sales (2020-2025)
3.3 Global Top Players by Antipyretic Analgesics Price (2020-2025)
3.4 Global Antipyretic Analgesics Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Antipyretic Analgesics Major Company Production Sites & Headquarters
3.6 Global Antipyretic Analgesics Company, Product Type & Application
3.7 Global Antipyretic Analgesics Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Antipyretic Analgesics Market CR5 and HHI
3.8.2 Global Top 5 and 10 Antipyretic Analgesics Players Market Share by Revenue in 2024
3.8.3 2023 Antipyretic Analgesics Tier 1, Tier 2, and Tier 3
4 Antipyretic Analgesics Regional Status and Outlook

4.1 Global Antipyretic Analgesics Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Antipyretic Analgesics Historic Market Size by Region
4.2.1 Global Antipyretic Analgesics Sales in Volume by Region (2020-2025)
4.2.2 Global Antipyretic Analgesics Sales in Value by Region (2020-2025)
4.2.3 Global Antipyretic Analgesics Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Antipyretic Analgesics Forecasted Market Size by Region
4.3.1 Global Antipyretic Analgesics Sales in Volume by Region (2026-2031)
4.3.2 Global Antipyretic Analgesics Sales in Value by Region (2026-2031)
4.3.3 Global Antipyretic Analgesics Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Antipyretic Analgesics by Application

5.1 Antipyretic Analgesics Market by Application
5.1.1 Adults
5.1.2 Children
5.2 Global Antipyretic Analgesics Market Size by Application
5.2.1 Global Antipyretic Analgesics Market Size Overview by Application (2020-2031)
5.2.2 Global Antipyretic Analgesics Historic Market Size Review by Application (2020-2025)
5.2.3 Global Antipyretic Analgesics Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Antipyretic Analgesics Sales Breakdown by Application (2020-2025)
5.3.2 Europe Antipyretic Analgesics Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Antipyretic Analgesics Sales Breakdown by Application (2020-2025)
5.3.4 South America Antipyretic Analgesics Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Antipyretic Analgesics Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Mallinckrodt Pharmaceuticals
6.1.1 Mallinckrodt Pharmaceuticals Comapny Information
6.1.2 Mallinckrodt Pharmaceuticals Business Overview
6.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.1.5 Mallinckrodt Pharmaceuticals Recent Developments
6.2 IOL
6.2.1 IOL Comapny Information
6.2.2 IOL Business Overview
6.2.3 IOL Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IOL Antipyretic Analgesics Product Portfolio
6.2.5 IOL Recent Developments
6.3 Anqiu Lu'an Pharmaceutical
6.3.1 Anqiu Lu'an Pharmaceutical Comapny Information
6.3.2 Anqiu Lu'an Pharmaceutical Business Overview
6.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
6.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
6.4 Novacyl
6.4.1 Novacyl Comapny Information
6.4.2 Novacyl Business Overview
6.4.3 Novacyl Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novacyl Antipyretic Analgesics Product Portfolio
6.4.5 Novacyl Recent Developments
6.5 BASF
6.5.1 BASF Comapny Information
6.5.2 BASF Business Overview
6.5.3 BASF Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BASF Antipyretic Analgesics Product Portfolio
6.5.5 BASF Recent Developments
6.6 Anhui BBCA Pharmaceuticals
6.6.1 Anhui BBCA Pharmaceuticals Comapny Information
6.6.2 Anhui BBCA Pharmaceuticals Business Overview
6.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
6.6.5 Anhui BBCA Pharmaceuticals Recent Developments
6.7 Hubei Biocause
6.7.1 Hubei Biocause Comapny Information
6.7.2 Hubei Biocause Business Overview
6.7.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
6.7.5 Hubei Biocause Recent Developments
6.8 Xinhua Pharm
6.8.1 Xinhua Pharm Comapny Information
6.8.2 Xinhua Pharm Business Overview
6.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
6.8.5 Xinhua Pharm Recent Developments
6.9 Granules India Limited
6.9.1 Granules India Limited Comapny Information
6.9.2 Granules India Limited Business Overview
6.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
6.9.5 Granules India Limited Recent Developments
6.10 Huagang Pharm
6.10.1 Huagang Pharm Comapny Information
6.10.2 Huagang Pharm Business Overview
6.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
6.10.5 Huagang Pharm Recent Developments
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Comapny Information
6.11.2 Hebei Jiheng Pharmaceutical Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Comapny Information
6.12.2 Zhejiang Kangle Pharmaceutical Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Comapny Information
6.13.2 Hebei Jingye Medical Technology Business Overview
6.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments
6.14 MSPF
6.14.1 MSPF Comapny Information
6.14.2 MSPF Business Overview
6.14.3 MSPF Antipyretic Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 MSPF Antipyretic Analgesics Product Portfolio
6.14.5 MSPF Recent Developments
7 North America by Country

7.1 North America Antipyretic Analgesics Sales by Country
7.1.1 North America Antipyretic Analgesics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Antipyretic Analgesics Sales by Country (2020-2025)
7.1.3 North America Antipyretic Analgesics Sales Forecast by Country (2026-2031)
7.2 North America Antipyretic Analgesics Market Size by Country
7.2.1 North America Antipyretic Analgesics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Antipyretic Analgesics Market Size by Country (2020-2025)
7.2.3 North America Antipyretic Analgesics Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Antipyretic Analgesics Sales by Country
8.1.1 Europe Antipyretic Analgesics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Antipyretic Analgesics Sales by Country (2020-2025)
8.1.3 Europe Antipyretic Analgesics Sales Forecast by Country (2026-2031)
8.2 Europe Antipyretic Analgesics Market Size by Country
8.2.1 Europe Antipyretic Analgesics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Antipyretic Analgesics Market Size by Country (2020-2025)
8.2.3 Europe Antipyretic Analgesics Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Antipyretic Analgesics Sales by Country
9.1.1 Asia-Pacific Antipyretic Analgesics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Antipyretic Analgesics Sales by Country (2020-2025)
9.1.3 Asia-Pacific Antipyretic Analgesics Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Antipyretic Analgesics Market Size by Country
9.2.1 Asia-Pacific Antipyretic Analgesics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Antipyretic Analgesics Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Antipyretic Analgesics Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Antipyretic Analgesics Sales by Country
10.1.1 South America Antipyretic Analgesics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Antipyretic Analgesics Sales by Country (2020-2025)
10.1.3 South America Antipyretic Analgesics Sales Forecast by Country (2026-2031)
10.2 South America Antipyretic Analgesics Market Size by Country
10.2.1 South America Antipyretic Analgesics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Antipyretic Analgesics Market Size by Country (2020-2025)
10.2.3 South America Antipyretic Analgesics Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Antipyretic Analgesics Sales by Country
11.1.1 Middle East and Africa Antipyretic Analgesics Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2020-2025)
11.1.3 Middle East and Africa Antipyretic Analgesics Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Antipyretic Analgesics Market Size by Country
11.2.1 Middle East and Africa Antipyretic Analgesics Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Antipyretic Analgesics Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Antipyretic Analgesics Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Antipyretic Analgesics Value Chain Analysis
12.1.1 Antipyretic Analgesics Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Antipyretic Analgesics Production Mode & Process
12.2 Antipyretic Analgesics Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Antipyretic Analgesics Distributors
12.2.3 Antipyretic Analgesics Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.